Total Funding
36
15
Total FundingNon-equity Assistance raised
Growth Score 36 in past quarter
-3 pts
Heat Score 15 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
264474
We provide phenotypic compound screening services for first-in-class drug discovery and drug repositioning
Ayla Annac: CEO and President- Tetsuro Wakatsuki: Chief Scientific Officer
About the Company
We provide phenotypic compound screening services for first-in-class drug discovery and drug repositioning. Our unique combination of tissue engineering technology with assay automation and sample miniaturization offers a rapid and cost effective platform for unprecedented therapeutic discovery.As our name implies, the core of InvivoSciences
mission is the research and development of engineered tissue-based assays that are superior because they mimic the function of living organisms, specifically those of animals and humans.
Women Founded
Women Led
